These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

625 related articles for article (PubMed ID: 35104835)

  • 41. Audio Interview: Understanding the Omicron Variant of SARS-CoV-2.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2022 Feb; 386(8):e27. PubMed ID: 35196435
    [No Abstract]   [Full Text] [Related]  

  • 42. Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection.
    Fuentes-Prior P
    J Biol Chem; 2021; 296():100135. PubMed ID: 33268377
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SARS-CoV-2 Evolution: On the Sudden Appearance of the Omicron Variant.
    Berkhout B; Herrera-Carrillo E
    J Virol; 2022 Apr; 96(7):e0009022. PubMed ID: 35293771
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Increasing the frequency of omicron variant mutations boosts the immune response and may reduce the virus virulence.
    Dawood AA
    Microb Pathog; 2022 Mar; 164():105400. PubMed ID: 35077833
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cryo-EM structure of a SARS-CoV-2 omicron spike protein ectodomain.
    Ye G; Liu B; Li F
    Nat Commun; 2022 Mar; 13(1):1214. PubMed ID: 35241675
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5.
    Tamura T; Yamasoba D; Oda Y; Ito J; Kamasaki T; Nao N; Hashimoto R; Fujioka Y; Suzuki R; Wang L; Ito H; Kashima Y; Kimura I; Kishimoto M; Tsuda M; Sawa H; Yoshimatsu K; Yamamoto Y; Nagamoto T; Kanamune J; Suzuki Y; Ohba Y; ; Yokota I; Matsuno K; Takayama K; Tanaka S; Sato K; Fukuhara T
    Commun Biol; 2023 Jul; 6(1):772. PubMed ID: 37488344
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The SARS-CoV-2 and other human coronavirus spike proteins are fine-tuned towards temperature and proteases of the human airways.
    Laporte M; Raeymaekers V; Van Berwaer R; Vandeput J; Marchand-Casas I; Thibaut HJ; Van Looveren D; Martens K; Hoffmann M; Maes P; Pöhlmann S; Naesens L; Stevaert A
    PLoS Pathog; 2021 Apr; 17(4):e1009500. PubMed ID: 33886690
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells.
    Zhao H; Lu L; Peng Z; Chen LL; Meng X; Zhang C; Ip JD; Chan WM; Chu AW; Chan KH; Jin DY; Chen H; Yuen KY; To KK
    Emerg Microbes Infect; 2022 Dec; 11(1):277-283. PubMed ID: 34951565
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drastic decline in sera neutralization against SARS-CoV-2 Omicron variant in Wuhan COVID-19 convalescents.
    Ma C; Chen X; Mei F; Xiong Q; Liu Q; Dong L; Liu C; Zou W; Zhan F; Hu B; Liu Y; Liu F; Zhou L; Xu J; Jiang Y; Xu K; Cai K; Chen Y; Yan H; Lan K
    Emerg Microbes Infect; 2022 Dec; 11(1):567-572. PubMed ID: 35060426
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expansion of L452R-Positive SARS-CoV-2 Omicron Variant, Northern Lombardy, Italy.
    Novazzi F; Baj A; Genoni A; Focosi D; Maggi F
    Emerg Infect Dis; 2022 Jun; 28(6):1301-1302. PubMed ID: 35416767
    [TBL] [Abstract][Full Text] [Related]  

  • 51. SARS-CoV-2 Bearing a Mutation at the S1/S2 Cleavage Site Exhibits Attenuated Virulence and Confers Protective Immunity.
    Sasaki M; Toba S; Itakura Y; Chambaro HM; Kishimoto M; Tabata K; Intaruck K; Uemura K; Sanaki T; Sato A; Hall WW; Orba Y; Sawa H
    mBio; 2021 Aug; 12(4):e0141521. PubMed ID: 34425707
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SARS-CoV-2 Omicron variant causes mild pathology in the upper and lower respiratory tract of hamsters.
    Armando F; Beythien G; Kaiser FK; Allnoch L; Heydemann L; Rosiak M; Becker S; Gonzalez-Hernandez M; Lamers MM; Haagmans BL; Guilfoyle K; van Amerongen G; Ciurkiewicz M; Osterhaus ADME; Baumgärtner W
    Nat Commun; 2022 Jun; 13(1):3519. PubMed ID: 35725735
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characteristics of replication and pathogenicity of SARS-CoV-2 Alpha and Delta isolates.
    Feng XL; Yu D; Zhang M; Li X; Zou QC; Ma W; Han JB; Xu L; Yang C; Qu W; Deng ZH; Long J; Long Y; Li M; Yao YG; Dong XQ; Zeng J; Li MH
    Virol Sin; 2022 Dec; 37(6):804-812. PubMed ID: 36167254
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SARS-CoV-2 omicron variants harbor spike protein mutations responsible for their attenuated fusogenic phenotype.
    Park SB; Khan M; Chiliveri SC; Hu X; Irvin P; Leek M; Grieshaber A; Hu Z; Jang ES; Bax A; Liang TJ
    Commun Biol; 2023 May; 6(1):556. PubMed ID: 37225764
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhancing epidemiological surveillance of the emergence of the SARS-CoV-2 Omicron variant using spike gene target failure data, England, 15 November to 31 December 2021.
    Blomquist PB; Bridgen J; Bray N; O'Connell AM; West D; Groves N; Gallagher E; Utsi L; Jarvis CI; Hardstaff JL; Byers C; Metelmann S; Simons D; Zaidi A; Twohig KA; Savagar B; Løchen A; Ryan C; Wrenn K; Saavedra-Campos M; Abedin Z; Florence I; Cleary P; Elson R; Vivancos R; Lake IR
    Euro Surveill; 2022 Mar; 27(11):. PubMed ID: 35301981
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Analysis of SARS-CoV-2 omicron mutations that emerged during long-term replication in a lung cancer xenograft mouse model.
    Baek K; Kim D; Kim J; Kang BM; Park H; Park S; Shin HE; Lee MH; Maharjan S; Kim M; Kim S; Park MS; Lee Y; Kwon HJ
    Virus Genes; 2024 Jun; 60(3):251-262. PubMed ID: 38587722
    [TBL] [Abstract][Full Text] [Related]  

  • 57. COVID-19: Omicron - the latest, the least virulent, but probably not the last variant of concern of SARS-CoV-2.
    Brüssow H
    Microb Biotechnol; 2022 Jul; 15(7):1927-1939. PubMed ID: 35443078
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics.
    Meo SA; Meo AS; Al-Jassir FF; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8012-8018. PubMed ID: 34982465
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents.
    Uraki R; Halfmann PJ; Iida S; Yamayoshi S; Furusawa Y; Kiso M; Ito M; Iwatsuki-Horimoto K; Mine S; Kuroda M; Maemura T; Sakai-Tagawa Y; Ueki H; Li R; Liu Y; Larson D; Fukushi S; Watanabe S; Maeda K; Pekosz A; Kandeil A; Webby RJ; Wang Z; Imai M; Suzuki T; Kawaoka Y
    Nature; 2022 Dec; 612(7940):540-545. PubMed ID: 36323336
    [TBL] [Abstract][Full Text] [Related]  

  • 60. S-acylation of SARS-CoV-2 spike protein: Mechanistic dissection, in vitro reconstitution and role in viral infectivity.
    Puthenveetil R; Lun CM; Murphy RE; Healy LB; Vilmen G; Christenson ET; Freed EO; Banerjee A
    J Biol Chem; 2021 Oct; 297(4):101112. PubMed ID: 34428449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.